TWD 51.5
(-2.83%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 13.24 Million TWD | -55.26% |
2022 | 29.59 Million TWD | 148.81% |
2021 | 11.89 Million TWD | -10.99% |
2020 | 13.36 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 12.19 Million TWD | -7.86% |
2024 Q2 | 36.89 Million TWD | 202.41% |
2023 Q3 | 15.23 Million TWD | -6.42% |
2023 FY | 13.24 Million TWD | -55.26% |
2023 Q1 | 6.29 Million TWD | -78.74% |
2023 Q2 | 16.28 Million TWD | 158.74% |
2023 Q4 | 13.24 Million TWD | -13.09% |
2022 Q4 | 29.59 Million TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Allied Biotech Corporation | 796.6 Million TWD | 98.338% |
GeneFerm Biotechnology Co., Ltd. | 152.07 Million TWD | 91.294% |
Easywell Biomedicals, Inc. | 386.34 Million TWD | 96.573% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 99.309% |
Synmosa Biopharma Corporation | 2.43 Billion TWD | 99.457% |
Orient EuroPharma Co., Ltd. | 4.84 Billion TWD | 99.727% |
Center Laboratories, Inc. | 5.62 Billion TWD | 99.765% |
Tien Liang BioTech Co., Ltd. | 84.65 Million TWD | 84.361% |
Orient Pharma Co., Ltd. | 716.92 Million TWD | 98.153% |
InnoPharmax Inc. | 21.49 Million TWD | 38.416% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 160.83 Million TWD | 91.768% |
Excelsior Biopharma Inc. | 377.4 Million TWD | 96.492% |
DV Biomed Co., Ltd. | 387.69 Million TWD | 96.585% |
Foresee Pharmaceuticals Co., Ltd. | 228.25 Million TWD | 94.2% |
UniPharma Co., Ltd. | 277 Thousand TWD | -4679.783% |
Anxo Pharmaceutical Co., Ltd. | 787.84 Million TWD | 98.319% |
Alar Pharmaceuticals Inc. | 1.4 Million TWD | -839.674% |
Winston Medical Supply Co., Ltd. | 107.32 Million TWD | 87.664% |
Mercury Biopharmaceutical Corporation | 42.34 Million TWD | 68.736% |
Bioray Biotech Co., Ltd | 69.79 Million TWD | 81.029% |
TSH Biopharm Corporation Limited | 7.84 Million TWD | -68.813% |